Menopause is a natural, physiological transition in a woman’s life, characterized by the cessation of the ovaries' reproductive and hormonal functions. Clinically, menopause is confirmed when a woman has gone 12 consecutive months without a menstrual period. This phase triggers massive endocrine shifts throughout the body, profoundly impacting estrogen-dependent organs—first and foremost, the breasts. As breast specialists, we consider menopause to be one of the most critical

In the process of diagnosing breast conditions, hearing the word "biopsy" is often the most stressful moment for a patient. Due to an information vacuum and many persistent myths, the term is frequently associated with an immediate cancer sentence. As a practicing breast specialist and clinician, I want to clarify this unequivocally: A breast biopsy is simply the most accurate, modern, and indispensable tool we have for gathering information in breast oncology. In this artic

In the multidisciplinary fight against breast cancer, early and precise diagnosis remains our most formidable weapon. Modern clinical oncology has undergone a significant paradigm shift, transitioning from an obsolete "one-size-fits-all" model to highly individualized, personalized screening protocols. Today, the selection of breast imaging modalities is meticulously tailored to the patient’s age, specific clinical risk factors, genetic predisposition, and mammographic tissue

As a physician specializing in breast health, one of the most common reasons I see patients for a follow-up consultation is an abnormal mammogram showing breast microcalcifications. Hearing that you have "calcifications" in your breast can be incredibly anxiety-inducing. However, I always start by reassuring my patients: microcalcifications are not a disease. They are simply a radiological finding—tiny, microscopic deposits of calcium salts within the breast tissue. Because t

Breast Density in contemporary mammology and radiology is considered a complex morphofunctional phenotype that reflects the structural organization of the breast parenchyma. It represents a clinically significant biomarker in the context of both diagnostic accuracy and oncological risk assessment. This parameter does not belong to the category of pathological conditions; however, it has a substantial impact on the efficacy of screening programs and the process of individual r

In our previous discussions on pregnancy and breast health, we highlighted the critical role of mammological screenings. However, throughout my 25-year career as a breast surgeon and surgical oncologist, I have had to deliver many difficult diagnoses. Perhaps the most poignant moment in clinical practice is when a young patient, grappling with her diagnosis, asks: "Will I ever be able to become a mother?" The intersection of breast cancer and fertility is a vital topic in mod